期刊文献+
共找到174篇文章
< 1 2 9 >
每页显示 20 50 100
The Application Value of Swan-Neck Microcatheter in Peripheral Vascular Interventional Therapy
1
作者 Xiang Zheng Ruidong Zhao Yao Zhou 《Journal of Biosciences and Medicines》 2024年第9期132-141,共10页
Background and Objectives: Establishing a stable pathway is the basis for interventional surgery, and hyper-selected intubation has become the basic requirement for vascular intervention therapy. Super-selection intub... Background and Objectives: Establishing a stable pathway is the basis for interventional surgery, and hyper-selected intubation has become the basic requirement for vascular intervention therapy. Super-selection intubation can not only significantly improve the efficacy of peripheral intervention treatment, but also greatly reduce surgical complications. However, during the treatment of peripheral vascular intervention (such as liver tumor arterial chemotherapy embolism, hemoptysis bronchial arterial embolism, gastrointestinal hemorrhagic gastrointestinal arterial embolism, etc.), vascular mutation is often large, and there are many branches, and the direction of blood flow is into the direction of blood flow, the horns are even reverse, and even the use of straight-headed microstructures will have difficulty interpolation difficulties or even failure, which increases the risk of surgery and affects safety treatment. To overcome this, pre-plasticized microcatheters have emerged, among which the InstantPass Swan-Neck Microstructure is a catheter with a head-end morphology similar to Cobra. Our research aims to explore the feasibility, safety, and technical advantages of the use of swan-neck microcatheter in peripheral vascular hyperboloid intubation. Materials and Methods: From January 2023 to March 2024, 31 patients with swan-neck microstructure were used in the peripheral vascular intervention therapy outside the hospital. Among them, there were 23 men and 8 women, aged 32 - 81 years old, an average (55 ± 13) years, and the average irradiation time was 35.1 ± 24.7 minutes. 10 cases of iodide oil arterial chemotherapy embolism, 7 cases of microspheres of hepatic arteries, 3 cases of gastric duodenal artery selective embolism, 3 cases of vein embolism with esophageal stomach, and 2 cases of sperm varicose vein embolism, 2 cases of selective embolism of the intestinal membrane, 2 cases of uterine arteries embolism, and 2 cases of renal arterial embolism. 11 of these patients switched to the swan-neck microstructure after using the straight-headed microstructure super-selective intubation. To analyze whether the swan-neck microcatheter is successfully transported to the target location, whether it can provide a satisfactory path for subsequent intravascular treatment, evaluate the surgery instant image results and complications related to the microstructure during the surgery period, analyze the angle of the target blood vessels and the main blood vessels, the target blood vessels, the target blood vessels, the relationship between the degree of pedestrian and the success rate of ultra-selective intubation, and summarize the indication of the application of the swan-neck microstructure in peripheral intervention therapy. Results: In this study, 31 patients used 31 swan-neck microcatheters, of which 22 (70.9%) target vascular and main blood vessels were ≤90˚;17 patients (54.8%) patients were curved and angulated;11 cases (35.5%) were after the failure of the superselective intubation of the straight-headed microstructure, the swan-neck microcatheter was successful after the failure;1 case (3.2%) patients with microstructure-related mezzanine occurred during surgery, and the complication rate of the perioperative ductation was 3.2%. All target lesions are finally successfully completed, and the success rate of surgical technology is 100%. Conclusion: Swan-neck microcatheters have a high success rate in superselective cannulation of peripheral blood vessels and perform well in vascular tortuosity and angulated lesions. 展开更多
关键词 Peripheral Artery Superselective Catheterization swan-neck microcatheter
下载PDF
Efficacy and safety of Usights UC100 illuminated microcatheter in microcatheter-assisted trabeculotomy
2
作者 Shuo Yu Ke Xu Chun Zhang 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2024年第2期272-277,共6页
AIM:To evaluate the efficacy and safety of Usights UC100 illuminated microcatheter in microcatheter-assisted trabeculotomy(MAT).METHODS:Totally 10 eyes of 10 patients with primary open angle glaucoma(POAG)who underwen... AIM:To evaluate the efficacy and safety of Usights UC100 illuminated microcatheter in microcatheter-assisted trabeculotomy(MAT).METHODS:Totally 10 eyes of 10 patients with primary open angle glaucoma(POAG)who underwent MAT facilitated by Usights UC100(5 eyes)or iTrack(5 eyes)were reviewed.The success of this surgery was defined as intraocular pressure(IOP)<22 mm Hg with>30%reduction,without oral glaucoma medications,or additional glaucoma surgery.RESULTS:The mean pre-operative IOP was 25.38±10.22 mm Hg in the Usights UC100 group and 19.98±3.87 mm Hg in the iTrack group.MAT was achieved in all eyes in both groups.The success rates for the Usights UC100 group and iTrack groups were in all and 4 eyes,respectively.Both microcatheters produced a statistically significant reduction in IOP,and eyes using Usights UC100 achieved a lower IOP than the iTrack group at 3mo followup(12.58±1.52 and 14.84±1.89 mm Hg,respectively),but no statistical significance was there.No severe side effects were observed in either group.CONCLUSION:MAT using Usights UC100 or iTrack both achieve significant pressure reduction in cases of POAG,and Usights UC100 is as safe as iTrack. 展开更多
关键词 illuminated microcatheter microcatheterassisted trabeculotomy primary open angle glaucoma
下载PDF
Establishment of a rhesus monkey model of middle cerebral artery ischemia and reperfusion using a microcatheter embolization method 被引量:2
3
作者 Jie Yang Jian Guo +10 位作者 Hongbo Zheng Muke Zhou Li He Wenying Cao Li Xiao Jiachuan Duan Qiyong Gong Xiaoqi Huang Hongxia Li Li Wang Jingqiu Cheng 《Neural Regeneration Research》 SCIE CAS CSCD 2010年第15期1161-1165,共5页
Nonhuman primates are closest to humans in terms of lineage, and middle cerebral artery ischemia/reperfusion responses of nonhuman primates are most similar to ischemic stroke in humans. Therefore, nonhuman primates c... Nonhuman primates are closest to humans in terms of lineage, and middle cerebral artery ischemia/reperfusion responses of nonhuman primates are most similar to ischemic stroke in humans. Therefore, nonhuman primates could be utilized to simulate the process of ischemic stroke in the human. Few studies, however, have reported the use of endovascular technology to establish a rhesus monkey stroke model. In the present study, seven adult, male, rhesus monkeys were selected and, following anesthesia, a microcatheter was inserted into one side of the middle cerebral artery via the femoral artery to block blood flow, thereby resulting in middle cerebral artery occlusion. After 2 hours, the microcatheter was withdrawn to restore the middle cerebral artery blood flow and to establish ischemia/reperfusion. Results from angiography and magnetic resonance angiography confirmed occlusion and reopening of the middle cerebral artery. Magnetic resonance imaging revealed the existence of ischemic brain lesions, and neurological examination showed sustained functional deficits following surgery. The rhesus monkey middle cerebral artery ischemia/reperfusion models established by microcatheter embolization had the advantage of non-craniotomy invasion and reproducibility. The scope and degree of ischemic damage using this model was controllable. Therefore, this nonhuman primate model is an ideal model for cerebral ischemia and reperfusion. 展开更多
关键词 ISCHEMIA REPERFUSION middle cerebral artery microcatheter magnetic resonance imaging rhesus monkey brain injury neural regeneration
下载PDF
Three benefits of microcatheters for retrograde transvenous obliteration of gastric varices 被引量:5
4
作者 Tetsuo Sonomura Wataru Ono +7 位作者 Morio Sato Shinya Sahara Kouhei Nakata Hiroki Sanda Nobuyuki Kawai Hiroki Minamiguchi Motoki Nakai Kazushi Kishi 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第12期1373-1378,共6页
AIM: To evaluate the usefulness of the microcatheter techniques in balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices.METHODS: Fifty-six patients with gastric varices underwent BRTOs us... AIM: To evaluate the usefulness of the microcatheter techniques in balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices.METHODS: Fifty-six patients with gastric varices underwent BRTOs using microcatheters. A balloon catheter was inserted into gastrorenal or gastrocaval shunts. A microcatheter was navigated close to the varices, and sclerosant was injected into the varices through the microcatheter during balloon occlusion. The next morning, thrombosis of the varices was evaluated by contrast enhanced computed tomography (CE-CT). In patients with incomplete thrombosis of the varices, a second BRTO was performed the following day. Patients were followed up with CE-CT and endoscopy.RESULTS: In all 56 patients, sclerosant was selectively injected through the microcatheter close to the varices. In 9 patients, microcoil embolization of collateral veinswas performed using a microcatheter. In 12 patients with incomplete thrombosis of the varices, additional injection of sclerosant was performed through the microcatheter that remained inserted overnight. Complete thrombosis of the varices was achieved in 51 of 56 patients, and the remaining 5 patients showed incomplete thrombosis of the varices. No recurrence of the varices was found in the successful 51 patients after a median follow up time of 10.5 too. We experienced one case of liver necrosis, and the other complications were transient.CONCLUSION: The microcatheter techniques are very effective methods for achieving a higher success rate of BRTO procedures, 展开更多
关键词 Balloon-occluded retrograde transvenousobliteration Gastric varices microcatheter Portal hyper-tension Ethanolamine oleate
下载PDF
Efficacy of microcatheter-assisted trabeculotomy on secondary glaucoma after congenital cataract surgery 被引量:1
5
作者 Wen-Jing Zhang Ying Qi +1 位作者 Xue-Tao Huang Ren-Jie Yao 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2022年第10期1604-1610,共7页
AIM: To evaluate efficacy of microcatheter-assisted trabeculotomy(MAT) in eyes with secondary glaucoma after congenital cataract surgery and explore its correlation with the different degree of trabeculotomy. METHODS:... AIM: To evaluate efficacy of microcatheter-assisted trabeculotomy(MAT) in eyes with secondary glaucoma after congenital cataract surgery and explore its correlation with the different degree of trabeculotomy. METHODS: A retrospective analysis was conducted on patients who underwent the said procedure between September 2019 and September 2020. The patients were classified into two groups according to the degree of trabeculotomy(group 1: ≤240-degree;group 2: 240–360-degree). The intraocular pressure(IOP) and antiglaucoma drugs before and after operation was collected during the 12-month follow-up. RESULTS: Totally 27 eyes of 25 patients were included: 11(40.7%) eyes in group 1 and 16(59.3%) eyes in group 2. The mean IOP of all patients was 34.67±9.18 mm Hg preoperatively and 8.74±4.32, 9.95±5.65, 14.39±5.30, 16.02±4.37, 15.82±3.28, and 16.19±3.56 mm Hg 1 d, 1 wk, 1, 3, 6, and 12 mo after surgery, respectively. In all patients, there were significant differences in IOP at each time point(F=65.614, P<0.01). In each group, IOP after surgery was lower than that before surgery(all P<0.01), but there was no difference in the rate of IOP reduction between the two groups(P=0.246). Furthermore, the amount of anti-glaucoma medications reduced to 0.30±0.67(0–2) at 12 mo from 2.63±0.49(2–3) preoperatively(P<0.01), and there was no difference between the two groups(P>0.05). At the end of follow-up, the partial success rate was 81.8% in group 1 vs 93.75% in group 2(P=0.549). Various amount of intraoperative and postoperative hyphema occurred in all eyes, which spontaneously absorbed or cleaned through paracentesis and irrigation. No other serious complications was observed.CONCLUSION: MAT can effectively reduce IOP in patients with secondary glaucoma after congenital cataract surgery with a high success rate and safety. And it can be used as the first choice for the treatment of secondary glaucoma after surgery for congenital cataracts. 展开更多
关键词 secondary glaucoma congenital cataract microcatheter-assisted trabeculotomy illuminated microcatheter intraocular pressure
下载PDF
Steerable microcatheters for complex percutaneous coronary interventions in octogenarians: from Venture to Swift Ninja
6
作者 George Kassimis Nestoras Kontogiannis Tushar Raina 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2019年第1期54-59,共6页
0ctogenarians represent the fastest growing group of patients undergoing percutaneous coronary intervention(PCI),now constituting more than one in five patients treated with PCI in real-world practice.[1,2]Comparing c... 0ctogenarians represent the fastest growing group of patients undergoing percutaneous coronary intervention(PCI),now constituting more than one in five patients treated with PCI in real-world practice.[1,2]Comparing coronary lesion characteristics of patients aged<≥80 years to those≥80 years undergoing PCI,the octogenarians have a higher prevalence of calcified and ostial lesions,tortuous coronary anatomy,multi-vessel disease and left main stem(LMS)stenosis.⑶Furthermore,they often have greater ischemic burden than their younger counterparts,suggesting an even greater benefit following revascularization. 展开更多
关键词 ACUTE angle branch OCTOGENARIANS Steerable microcatheters Supercross SWIFT NINJA VENTURE wire control CATHETER
下载PDF
Experimental circumferential canaloplasty with a new Schlemm canal microcatheter
7
作者 Mao-Song Xie Yong-Zheng Zheng +1 位作者 Li-Bin Huang Guo-Xing Xu 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第1期1-5,共5页
AIM: To present a new, simple, inexpensive Schlemm canal microcatheter for circumferential canaloplasty in a rabbit model. METHODS: A rabbit glaucoma animal model was established by intravitreal injection of triamci... AIM: To present a new, simple, inexpensive Schlemm canal microcatheter for circumferential canaloplasty in a rabbit model. METHODS: A rabbit glaucoma animal model was established by intravitreal injection of triamcinolone acetonide. Circumferential canaloplasty with a new Schlemm canal microcatheter(patent license number: 201220029850.0) was performed. The Schlemm canal microcatheter was composed of microcatheter wall and lumen. The wall was made of high refractive index plastic optical fiber that could be attached to an illuminant so that the whole lighted microcatheter was visible during circumferential canaloplasty. The lumen could be attached to an injector for injection of viscoelastic during catheterization. Rabbits were divided randomly into the control, model and treatment groups. Intraocular pressure(IOP) was measured with a Tono-pen tonometer pre-operation and 3, 7, 14, 21 and 28 d post-operation. Ultrasound biomicroscopy was performed to visualize the Schlemm canal microcatheter in the Schlemm canal and the sclera pool.RESULTS: The Schlemm canal microcatheter could be used to perform circumferential canaloplasty in the rabbit glaucoma animal model. IOP was lower in the treatment group than that in the model group 3, 7, 14 and 28 d after operation. There were no significant differences in IOP between the control group and treatment group. The differences among the three groups were statistically significant(3 d: F=41.985, P〈0.001; 7 d: F=65.696, P〈0.001; 14 d: F=114.599, P〈0.001; 28 d: F=55.006, P〈0.001).CONCLUSION: Circumferential canaloplasty is safe and effective in control of experimental glaucoma model in rabbits. 展开更多
关键词 glaucoma canaloplasty Schlemm canal microcatheter surgery
下载PDF
双腔微导管联合锚定球囊在经桡动脉6 F指引导管处理分叉病变中的应用分析
8
作者 关晓楠 马宁 +4 位作者 齐丹 刘文婷 宗敏 赵华 张建军 《中华老年心脑血管病杂志》 CAS 北大核心 2024年第10期1143-1146,共4页
目的探讨双腔微导管联合锚定球囊在经桡动脉6 F指引导管处理老年患者分叉病变中的应用效果。方法回顾性分析2020年1月至2023年1月在北京朝阳医院心脏中心就诊的年龄≥60岁接受经桡动脉6 F指引导管处理分叉患者168例,按是否采用双腔微导... 目的探讨双腔微导管联合锚定球囊在经桡动脉6 F指引导管处理老年患者分叉病变中的应用效果。方法回顾性分析2020年1月至2023年1月在北京朝阳医院心脏中心就诊的年龄≥60岁接受经桡动脉6 F指引导管处理分叉患者168例,按是否采用双腔微导管联合锚定球囊技术分为锚定组81例和对照组87例。比较2组冠状动脉病变特点、手术情况及主要不良心血管事件(major adverse cardiovascular events,MACE)。采用多因素logistic回归分析危险因素。结果锚定组边支夹层发生率、手术时间、X线曝光剂量、对比剂用量明显低于对照组(P<0.05,P<0.01)。锚定组术后12个月MACE发生率与对照组比较,差异无统计学意义(4.9%vs 8.0%,P>0.05)。边支夹层、边支最终血流心肌梗死溶栓试验<3级是老年分叉病变患者术后12个月MACE发生的独立危险因素(P<0.05,P<0.01)。结论双腔微导管联合锚定球囊技术在经桡动脉6 F指引导管处理分叉病变可有效缩短老年患者手术时间,减少X线曝光剂量,对比剂用量及边支夹层发生率。 展开更多
关键词 微导管 桡动脉 支架 冠状动脉疾病
下载PDF
3D打印技术辅助微导管塑形在颅内动脉瘤栓塞术中的应用探讨
9
作者 李奔 付星星 叶鹏 《世界复合医学》 2024年第1期156-160,共5页
目的探讨颅内动脉瘤栓塞术采用3D打印技术辅助微导管塑形的效果与应用价值。方法随机选取2021年1月—2023年6月于宿迁市中医院接受颅内动脉瘤栓塞术治疗的90例患者为研究对象,按照随机数表法分为对照组和观察组。对照组(n=45)采取传统... 目的探讨颅内动脉瘤栓塞术采用3D打印技术辅助微导管塑形的效果与应用价值。方法随机选取2021年1月—2023年6月于宿迁市中医院接受颅内动脉瘤栓塞术治疗的90例患者为研究对象,按照随机数表法分为对照组和观察组。对照组(n=45)采取传统栓塞术方式,观察组(n=45)采取3D打印技术辅助微导管塑形方式。比较两组的治疗效果、术前准备及术中操作所用时间;对患者进行为期3个月的随访,评估两组患者的预后恢复情况及生存质量。结果两组治疗总有效率对比,差异无统计学意义(P>0.05)。观察组术前准备及术中操作时间均短于对照组,差异有统计学意义(P均<0.05)。预后评估结果显示;观察组格拉斯哥预后(Glasgow Outcome Scale,GOS)评分为(4.52±0.18)分,高于对照组,改良Rankin量表(Modified Rankin Scale,MRS)评分为(1.35±0.17)分,低于对照组,差异均有统计学意义(t=35.787、43.201,P均<0.05)。此外,观察组术后生存质量评分高于对照组,差异有统计学意义(P<0.05)。结论临床以栓塞术治疗颅内动脉瘤疾病时可采用3D打印技术辅助微导管塑形方式,疗效确切,手术时间短,患者预后质量佳。 展开更多
关键词 3D打印技术 微导管塑形 颅内动脉瘤栓塞术 预后
下载PDF
微导管冠状动脉内精准溶栓治疗老年急性心肌梗死的作用
10
作者 王三怡 彭双双 李才 《中华老年心脑血管病杂志》 CAS 北大核心 2024年第9期1002-1006,共5页
目的 基于抑制心室重构和心肌保护作用探讨经微导管冠状动脉内精准溶栓治疗老年急性心肌梗死(acute myocardial infarction, AMI)的作用。方法 回顾性选择2022年1月至2023年1月南昌大学第二附属医院心内科住院的老年AMI患者106例,根据... 目的 基于抑制心室重构和心肌保护作用探讨经微导管冠状动脉内精准溶栓治疗老年急性心肌梗死(acute myocardial infarction, AMI)的作用。方法 回顾性选择2022年1月至2023年1月南昌大学第二附属医院心内科住院的老年AMI患者106例,根据治疗方法随机分为溶栓组50例和直接经皮冠状动脉介入治疗(percutaneous coronary intervention, PCI)组56例。术前和术后1个月采用心脏超声检测左心室舒张末期内径(left ventricular end-diastolic diameter, LVEDD)、左心室收缩末期内径(left ventricular end-systolic diameter, LVESD)、左心房内径(left atrial dimension, LAD)和左心室射血分数(left ventricular ejection fraction, LVEF)。检测肌酸激酶同工酶(creatine kinase isoenzymes-MB,CK-MB)、高敏肌钙蛋白T(high sensitivity cardiac troponin T,hs-cTnT)、高敏C反应蛋白(high sensitivity C-reactive protein, hs-CRP),随访术后30 d内主要不良心脏事件。观察药物不良反应。结果 直接PCI组术后1个月LVEDD、LVESD和LAD显著低于溶栓组[(40.08±5.18)mm vs(47.22±5.08)mm,(29.12±5.07)mm vs(35.33±5.13)mm,(33.07±5.07)mm vs(40.08±5.18)mm,P<0.01],LVEF显著高于溶栓组[(55.08±5.17)%vs(49.07±5.19)%,P<0.01]。2组术后LVEDD、LVESD、LAD显著低于术前,LVEF显著高于术前,差异有统计学意义(P<0.05)。2组术前、术后8 h及24 h的CK-MB、hs-cTnT、hs-CRP水平比较,差异有统计学意义(P<0.01)。2组术后8 h及24 h的CK-MB、hs-cTnT、hs-CRP水平显著高于术前,术后24 h的CK-MB、hs-cTnT、hs-CRP水平显著高于术后8 h,差异有统计学意义(P<0.05)。直接PCI组主要不良心脏事件比例显著高于溶栓组(16.1%vs 4.0%,P<0.05)。结论 经微导管冠状动脉内精准溶栓治疗可以明显改善老年AMI患者心室重构,起到心肌保护作用。 展开更多
关键词 心肌梗死 冠状血管 血栓溶解疗法 微导管
下载PDF
双微导管技术治疗颅内宽颈动脉瘤的疗效及对病人神经功能的影响
11
作者 马修尧 任超 +5 位作者 刘彬 成维鹏 胡萍 丁磊 周肖 范鹏坤 《临床外科杂志》 2024年第9期915-917,共3页
目的 探讨颅内宽颈动脉瘤(IWNA)病人采用双微导管技术治疗疗效及对病人神经功能影响。方法 采用前瞻性随机对照研究。2017年3月~2022年3月收治的IWNA病人55例,根据治疗方法分为两组,治疗组28例,采用双微导管介入治疗;对照组27例,采用支... 目的 探讨颅内宽颈动脉瘤(IWNA)病人采用双微导管技术治疗疗效及对病人神经功能影响。方法 采用前瞻性随机对照研究。2017年3月~2022年3月收治的IWNA病人55例,根据治疗方法分为两组,治疗组28例,采用双微导管介入治疗;对照组27例,采用支架辅助治疗。比较两组疗效、并发症发生率、术前和术后6个月NIHSS评分和ADL评分变化以及术后6个月预后情况。结果 治疗组总有效率为100.00%,对照组总有效率为96.30%,两组比较,差异无统计学意义(P>0.05)。治疗组并发症发生率(7.14%)少于对照组(33.33%),两组比较差异有统计学意义(P<0.05)。两组术后6个月NIHSS评分低于术前,而ADL评分高于术前,组内术后、术前比较,差异有统计学意义(P<0.05);治疗组术后6个月NIHSS评分[(8.76±0.87)分]低于对照组[(9.82±0.96)分],ADL评分[(57.82±5.43)分]高于对照组[(64.52±5.16)分],两组比较差异有统计学意义(P<0.05)。两组mRS评分比较,差异无统计学意义(P>0.05)。结论 双微导管技术治疗IWNA疗效较好,可降低并发症发生率,改善神经功能。 展开更多
关键词 双微导管技术 颅内宽颈动脉瘤 疗效 神经功能
下载PDF
血管内微导管介入治疗颅脑动脉瘤的效果及对患者预后的影响
12
作者 申猛 岳四海 陈清亮 《临床医学工程》 2024年第8期903-904,共2页
目的探讨血管内微导管介入治疗颅脑动脉瘤患者的效果及预后。方法90例颅脑动脉瘤患者随机分为观察组(血管内微导管介入)和对照组(开颅夹闭术),比较两组的手术情况、血清指标、并发症和预后。结果观察组的手术时间长于对照组,术中出血量... 目的探讨血管内微导管介入治疗颅脑动脉瘤患者的效果及预后。方法90例颅脑动脉瘤患者随机分为观察组(血管内微导管介入)和对照组(开颅夹闭术),比较两组的手术情况、血清指标、并发症和预后。结果观察组的手术时间长于对照组,术中出血量少于对照组,住院时间短于对照组,术后NF-kB、VEGF、sICAM-1水平以及并发症发生率均低于对照组(P<0.05)。两组的复发率比较,差异无统计学意义(P>0.05)。结论血管内微导管介入治疗颅脑动脉瘤患者的短期预后尚可。 展开更多
关键词 血管内微导管介入 颅脑动脉瘤 效果 预后
下载PDF
血管内微导管介入治疗脑动脉瘤的效果分析
13
作者 胡赞 姚永新 《中国社区医师》 2024年第9期29-31,共3页
目的:分析血管内微导管介入治疗脑动脉瘤的效果。方法:选取2020年2月—2023年4月湘潭市中心医院收治的脑动脉瘤患者70例作为研究对象。采用随机数字表法分为试验组、参照组,各35例。参照组采用夹闭手术治疗,试验组采用血管内微导管介入... 目的:分析血管内微导管介入治疗脑动脉瘤的效果。方法:选取2020年2月—2023年4月湘潭市中心医院收治的脑动脉瘤患者70例作为研究对象。采用随机数字表法分为试验组、参照组,各35例。参照组采用夹闭手术治疗,试验组采用血管内微导管介入治疗。比较两组治疗效果。结果:试验组治疗总有效率高于参照组,差异有统计学意义(P=0.003)。试验组手术时间、住院时间短于参照组,术中出血量少于参照组,差异有统计学意义(P<0.001)。试验组并发症总发生率低于参照组,差异有统计学意义(P=0.046)。治疗后,两组核因子κB、血管内皮生长因子、血清可溶性细胞间黏附分子-1水平低于治疗前,且试验组低于参照组,差异有统计学意义(P<0.05)。结论:血管微导管介入治疗脑动脉瘤的效果较好,可缩短手术时间,减少术中出血量,改善血清指标,降低并发症发生率,促进患者康复。 展开更多
关键词 血管内微导管介入 脑动脉瘤 夹闭手术
下载PDF
同轴微导管PVA栓塞介入治疗动脉性下消化道出血的研究
14
作者 孙泽西 王洋 赵菲 《广州医药》 2024年第8期869-874,共6页
目的研究同轴微导管聚乙烯醇颗粒(PVA)栓塞治疗动脉性下消化道出血患者的应用效果。方法本研究为前瞻性研究,选择河南科技大学第一附属医院2022年1月—2023年6月收治的118例动脉性下消化道出血患者为研究对象,以计算机随机分组法将其分... 目的研究同轴微导管聚乙烯醇颗粒(PVA)栓塞治疗动脉性下消化道出血患者的应用效果。方法本研究为前瞻性研究,选择河南科技大学第一附属医院2022年1月—2023年6月收治的118例动脉性下消化道出血患者为研究对象,以计算机随机分组法将其分为常规组和试验组,各59例。两组均行数字减影血管造影检查明确出血情况,常规组予以内镜下注射止血治疗,试验组经同轴微导管PVA栓塞进行止血治疗,比较两组患者的治疗效果及预后情况。结果在不同治疗方案下,试验组的技术成功率、临床成功率分别为89.83%(53/59)、84.75%(50/59),均高于常规组[71.19%(42/59)、64.41%(38/59)](χ^(2)=11.071、10.911,P<0.05);试验组的止血时间、凝血酶原时间(PT)、凝血酶时间(TT)分别为(50.25±10.37)min、(10.25±2.31)s、(16.33±4.47)s,均低于常规组[(55.36±10.72)min、(12.44±3.61)s、(19.35±4.23)s](t=2.632、3.925、3.769,P<0.05);试验组治疗后的动脉搏动指数(PI)、阻力指数(RI)分别为(1.12±0.33)(0.51±0.21),均低于常规组[(1.65±0.41)(0.73±0.22)](t=7.735、5.556,P<0.05);试验组治疗7、14、30 d后的再出血率分别为5.08%(3/59)、8.47%(5/59)、10.17%(6/59),均低于常规组[20.34%(12/59)、25.42%(15/59)、28.81%(17/59)](χ^(2)=10.495、10.207、11.071,P<0.05);试验组的并发症发生率8.47%(5/59)低于常规组22.03%(13/59),差异均具有统计学意义(χ^(2)=7.113,P<0.05)。结论与常规内镜下止血相比,同轴微导管PVA栓塞可显著提升动脉性下消化道出血患者的止血成功率,对缩短患者止血时间、促进凝血系统恢复、降低再出血风险及相关并发症发生风险均有积极意义。 展开更多
关键词 动脉性下消化道出血 同轴微导管 聚乙烯醇颗粒 介入栓塞 止血效果
下载PDF
微导管精准立体塑形技术治疗颅内动脉瘤介入栓塞的临床研究 被引量:2
15
作者 曾晓华 聂艳良 +1 位作者 熊叶 钟富军 《中国医学创新》 CAS 2023年第19期28-33,共6页
目的:探讨微导管精准立体塑形技术治疗颅内动脉瘤介入栓塞的临床效果。方法:选取2021年3月—2022年6月丰城市人民医院收治的60例颅内动脉瘤患者,按随机数字表法将其分为观察组(30例,行微导管精准立体塑形技术介入栓塞治疗)与对照组(30例... 目的:探讨微导管精准立体塑形技术治疗颅内动脉瘤介入栓塞的临床效果。方法:选取2021年3月—2022年6月丰城市人民医院收治的60例颅内动脉瘤患者,按随机数字表法将其分为观察组(30例,行微导管精准立体塑形技术介入栓塞治疗)与对照组(30例,行支架辅助治疗)。对比两组神经功能缺损评分、生活活动能力评分、住院时长,手术前后可溶性细胞间黏附分子-1(sICAM-1)和中枢神经特异性蛋白(S100β)水平,术后Raymond分级、并发症发生率及预后情况。结果:两组术前美国国立卫生研究院卒中量表(NIHSS)评分与日常生活活动能力评定量表(ADL)评分比较,差异均无统计学意义(P>0.05)。两组术后6个月NIHSS评分均低于术前,ADL评分均高于术前,观察组NIHSS评分低于对照组,ADL评分高于对照组,差异均有统计学意义(P<0.05)。观察组住院时长短于对照组(P<0.05)。两组术前血清sICAM-1、S100β水平比较,差异均无统计学意义(P>0.05),两组术后6个月血清sICAM-1、S100β水平均低于术前,且观察组均低于对照组(P<0.05);观察组术后Raymond分级Ⅰ级占比高于对照组(P<0.05);观察组术后并发症发生率为10.00%,低于对照组的36.67%(P<0.05);观察组预后恢复良好率为93.33%,高于对照组的70.00%(P<0.05)。结论:微导管精准立体塑形技术治疗颅内动脉瘤介入栓塞的疗效良好,能改善患者神经功能、日常活动能力,可调节sICAM-1、S100β水平,降低并发症发生率,预后效果好。 展开更多
关键词 颅内动脉瘤 微导管精准立体塑形技术 支架辅助弹簧圈栓塞 神经功能
下载PDF
术前智能化微导管塑形模拟技术辅助颅内未破裂动脉瘤栓塞术的安全性和有效性研究 被引量:2
16
作者 耿介文 胡鹏 +1 位作者 何川 张鸿祺 《中国脑血管病杂志》 CAS CSCD 北大核心 2023年第7期441-448,共8页
目的分析颅内未破裂动脉瘤栓塞术前智能化微导管塑形软件技术辅助的安全性和有效性,以及对低年资医师治疗效果的影响。方法前瞻性连续纳入首都医科大学宣武医院神经外科2020年12月至2021年9月行弹簧圈栓塞术的颅内未破裂动脉瘤患者,通... 目的分析颅内未破裂动脉瘤栓塞术前智能化微导管塑形软件技术辅助的安全性和有效性,以及对低年资医师治疗效果的影响。方法前瞻性连续纳入首都医科大学宣武医院神经外科2020年12月至2021年9月行弹簧圈栓塞术的颅内未破裂动脉瘤患者,通过中央随机系统将符合纳入与排除标准的患者随机分配到试验组和对照组,试验组采用颅内动脉瘤手术计划软件[强联智创(北京)科技有限公司]辅助下进行微导管塑形,对照组由神经外科医师根据自身诊疗经验进行微导管塑形。分析试验组和对照组患者有效性终点(微导管一次到位率、5 min微导管到位率、微导管输送到位时间、微导管输送次数、优良率)和安全性终点(围手术期出血和缺血事件、术后6个月动脉瘤复发)。为分析颅内动脉瘤手术计划软件辅助不同操作经验神经介入医师的有效性,进一步对独立操作年限≤5年的医师操作弹簧圈栓塞手术的有效性终点进行分析。结果共100例颅内未破裂动脉瘤患者,4例被排除(2例入组时发生破裂,2例为外院复发动脉瘤),最终纳入96例患者,其中试验组纳入49例患者49个动脉瘤,对照组纳入47例患者47个动脉瘤。试验组和对照组患者性别、年龄、基础病史(高血压病、高脂血症、糖尿病)、动脉瘤部位、规则动脉瘤、术者年限≤5年独立操作的差异均无统计学意义(均P>0.05)。试验组微导管5 min到位率、一次到位率、输送优良率均高于对照组[98.0%(48/49)比66.0%(31/47),χ^(2)=14.735;98.0%(48/49)比68.1%(32/47),χ^(2)=13.992;98.0%(48/49)比68.1%(32/47),χ^(2)=13.992],而输送到位时间和输送次数均少于对照组[34(17,51)s比200(123,478)s,Z=271.000;1(1,1)次比1(1,2)次,Z=804.000],组间差异均有统计学意义(均P<0.01)。试验组和对照组均未发生围手术期出血事件;试验组未发生围手术期缺血事件,对照组围手术期缺血事件发生率为4.3%(2/47),其中1例为左侧后交通穿支动脉梗死,1例为术中血栓,经对症治疗后均好转。术后6个月影像学随访率为43.8%(42/96),试验组与对照组动脉瘤复发占比的差异无统计学意义(P=1.000)。独立操作年限≤5年医师共行弹簧圈栓塞术30例,其中试验组微导管5 min到位占比、一次到位占比、输送优良占比均高于对照组(17/18比6/12,χ^(2)=5.660;17/18比8/12,χ^(2)=10.060;17/18比8/12,χ^(2)=10.060),输送到位时间短于对照组[34(11,58)s比294(71,726)s,Z=-3.409],输送次数少于对照组[1(1,1)次比1(1,2)次,Z=-2.023],组间差异均有统计学意义(均P<0.05)。结论术前智能化微导管塑形技术辅助有助于神经介入医师提升微导管塑形弹簧圈栓塞术的有效性,并且对于手术操作年限相对较短医师的栓塞操作有一定的辅助作用。 展开更多
关键词 颅内动脉瘤 微导管塑形 不同操作经验 人工智能 栓塞
下载PDF
3D打印技术辅助微导管塑形在颅内动脉瘤栓塞术中的应用 被引量:1
17
作者 张明辉 杨呈浩 +2 位作者 陈立珂 赖挺 丁昊 《介入放射学杂志》 CSCD 北大核心 2023年第8期800-803,共4页
目的 探讨3D打印技术辅助微导管塑形在颅内动脉瘤栓塞术中的应用价值。方法 纳入2020年5月至2022年1月自贡市第四人民医院采用3D打印辅助微导管塑形技术进行颅内动脉瘤栓塞治疗的32例患者(32枚动脉瘤),评判微导管塑形效果及动脉瘤栓塞... 目的 探讨3D打印技术辅助微导管塑形在颅内动脉瘤栓塞术中的应用价值。方法 纳入2020年5月至2022年1月自贡市第四人民医院采用3D打印辅助微导管塑形技术进行颅内动脉瘤栓塞治疗的32例患者(32枚动脉瘤),评判微导管塑形效果及动脉瘤栓塞结果。结果 32例患者微导管塑形均满意,一次到位成功,无重复塑形患者。26枚动脉瘤采用回撤技术使微导管落入动脉瘤腔,6枚动脉瘤通过微导丝引导入动脉瘤腔。所有患者栓塞术中微导管形态保持稳定,无微导管脱出事件。术后即刻血管造影显示,动脉瘤完全栓塞24枚,近全栓塞5枚,不全栓塞3枚。随访3个月,改良Rankin评分量表(mRS)评分0~2分29例,3~6分3例。结论 3D打印技术辅助微导管塑形方法应用于颅内动脉瘤栓塞术安全有效,有助于准确塑形微导管,顺利推进手术进程。 展开更多
关键词 三维打印技术 颅内动脉瘤 微导管 塑形 栓塞
下载PDF
双微导管介入栓塞治疗急性期颅内宽颈动脉瘤的疗效分析 被引量:1
18
作者 潘桂芳 唐超 李雯 《浙江医学》 CAS 2023年第20期2197-2201,共5页
目的分析双微导管介入栓塞治疗急性期颅内宽颈动脉瘤的疗效及预后影响因素。方法选择2018年1月至2022年12月浙江大学医学院附属第二医院临平院区收治的急性期颅内宽颈动脉瘤患者110例,均行双微导管介入栓塞治疗,观察双微导管介入栓塞治... 目的分析双微导管介入栓塞治疗急性期颅内宽颈动脉瘤的疗效及预后影响因素。方法选择2018年1月至2022年12月浙江大学医学院附属第二医院临平院区收治的急性期颅内宽颈动脉瘤患者110例,均行双微导管介入栓塞治疗,观察双微导管介入栓塞治疗后患者的栓塞率、术后1个月有效率及并发症情况。出院后随访6个月,在末次随访时采用神经功能预后量表(mRS)评分评估患者神经功能恢复情况,根据mRS评分结果将患者分为预后良好组和预后不良组。比较两组患者的临床特征,采用多因素logistic回归分析双微导管介入栓塞治疗急性期颅内宽颈动脉瘤预后不良的危险因素。结果110例患者手术均成功,术后即刻血管造影检查显示,栓塞率为96.36%(106/110)。术后1个月有效率91.67%(99/108)。术后发生电解质紊乱、肺部感染及发热各1例,脑积水和尿路感染各2例,术后并发症发生率为6.48%(7/108)。预后不良组年龄大于预后良好组,有高血压病史、术前Hunt-Hess分级Ⅲ~Ⅳ级者占比高于预后良好组,瘤颈宽度大于预后良好组,差异均有统计学意义(均P<0.05)。高血压病史、术前Hunt-Hess分级Ⅲ~Ⅳ级、瘤颈宽度等因素均是双微导管介入栓塞治疗急性期颅内宽颈动脉瘤预后不良的危险因素(均P<0.05)。结论双微导管介入栓塞治疗急性期颅内宽颈动脉瘤的临床效果显著,术后并发症发生率较低。患者若伴有高血压病史、术前Hunt Hess分级Ⅲ~Ⅳ级、瘤颈较宽时预后不良的发生风险增高,在诊治过程中应予关注。 展开更多
关键词 双微导管介入栓塞 急性期 颅内宽颈动脉瘤 预后 危险因素
下载PDF
利用3D打印技术体外模拟微导管塑形在颅内动脉瘤介入治疗中的应用 被引量:4
19
作者 李建东 伍雪晴 +3 位作者 崔艳峰 徐浩 高志康 沙俊诚 《介入放射学杂志》 CSCD 北大核心 2023年第6期527-532,共6页
目的探究3D打印技术在颅内动脉瘤介入治疗中的应用价值。方法选取徐州医科大学附属医院介入放射科2021年10月至2022年3月收治的经脑动脉造影术提示颅内动脉瘤的患者40例。将患者随机分为试验组20例,对照组20例。试验组术者利用3D-DSA数... 目的探究3D打印技术在颅内动脉瘤介入治疗中的应用价值。方法选取徐州医科大学附属医院介入放射科2021年10月至2022年3月收治的经脑动脉造影术提示颅内动脉瘤的患者40例。将患者随机分为试验组20例,对照组20例。试验组术者利用3D-DSA数据制作动脉瘤模型,通过术前模拟,术中辅助微导管塑形。对照组术者通过术中观察3D-DSA图像,凭借临床经验塑形微导管。比较两组术中微导管体外反复塑形的次数、微导管末次塑形后从指引导管至到达动脉瘤腔的时间、首次塑形微导管后微导管抵达动脉瘤腔的成功率、术中单根微导管塑形综合评分以及术后2个月改良Rankin量表(mRs)评分。结果试验组微导管体外反复塑形的次数为(1.30±0.47)次,微导管末次塑形后从指引导管至到达动脉瘤腔的时间为35.00(20.00,67.50)s,首次塑形微导管后微导管抵达动脉瘤腔的成功率为70%(14/20),术中微导管塑形综合评分为(3.15±0.99)分。对照组微导管体外反复塑形的次数为(1.75±0.64)次,微导管末次塑形后从指引导管至到达动脉瘤腔的时间为82.50(46.25,108.75)s,首次塑形微导管后微导管抵达动脉瘤腔的成功率为35%(7/20),术中微导管塑形综合评分为(2.25±1.29)分,两组比较差异有统计学意义(P<0.05)。试验组患者术后2个月mRs评分为(0.60±0.68)分,对照组患者术后2个月m Rs评分为(0.90±0.85)分,差异无统计学意义(P>0.05)。结论相较于传统微导管塑形方式,3D打印技术辅助微导管塑形可减少术中微导管反复塑形次数、缩短操作时间、提高微导管抵达动脉瘤腔的成功率和微导管塑形的精确度。 展开更多
关键词 3D打印 颅内动脉瘤 微导管塑形 动脉瘤介入栓塞术
下载PDF
无导丝微导管技术在急性缺血性卒中机械取栓中的应用
20
作者 崔焕喜 崔红凯 +4 位作者 裴观辉 李道广 孙广普 陈松 王明盛 《河南医学研究》 CAS 2023年第19期3478-3481,共4页
目的探讨无导丝微导管技术在急性大血管闭塞性缺血性卒中机械取栓术中通过血栓的可行性及安全性。方法回顾性分析新乡医学院第一附属医院神经介入科病区2020年7月至2022年7月收治111例急性缺血性卒中机械取栓患者的临床资料,根据通过血... 目的探讨无导丝微导管技术在急性大血管闭塞性缺血性卒中机械取栓术中通过血栓的可行性及安全性。方法回顾性分析新乡医学院第一附属医院神经介入科病区2020年7月至2022年7月收治111例急性缺血性卒中机械取栓患者的临床资料,根据通过血栓方式分为对照组(56例)和观察组(55例)。对照组通过血栓使用常规微导丝技术,观察组通过血栓采用无导丝微导管技术,两组患者均接受机械取栓治疗,比较两组首次通过血栓成功率及术中、术后对比剂外渗或蛛网膜下腔出血并发症发生情况。结果观察组一次性通过血栓成功率低于对照组,差异无统计学意义(P>0.05)。观察组术中血管造影蛛网膜下腔出血并发症发生率低于对照组,差异有统计学意义(P<0.05)。观察组术后颅脑CT蛛网膜下腔出血并发症发生率低于对照组,差异有统计学意义(P<0.05)。结论使用无导丝微导管技术通过血栓与常规微导丝技术通过血栓的一次性通过血栓成功率无明显差异,但无导丝微导管技术通过血栓能够减少对比剂外渗及蛛网膜下腔出血的风险,显示出更高的安全性。 展开更多
关键词 急性缺血性卒中 机械取栓 无导丝微导管技术 微导丝 微导管
下载PDF
上一页 1 2 9 下一页 到第
使用帮助 返回顶部